India has not accepted 'data exclusivity' demand by UK to protect generic drug firms

India has declined the UK's request for a 'data exclusivity' clause in their free trade agreement to safeguard its domestic generic drug industry. This decision mirrors a previous rejection of a similar demand from the EFTA bloc. The move aims to protect the flourishing generic drug sector, a key player in India's exports, from potential restrictions on producing affordable medicines.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/71ebJdW
via IFTTT